GeneHealth - Your precision medicine

Angiodysplasia

Disease Details

Family Health Simplified

Buy Membership

Description: Angiodysplasia is a condition characterized by abnormal, fragile blood vessels in the gastrointestinal tract, which can lead to bleeding and anemia.
Type: Angiodysplasia is generally not considered a hereditary condition. It is typically an acquired vascular anomaly rather than one that follows a specific type of genetic transmission. Factors such as age-related degeneration and other underlying medical conditions are more commonly implicated in its development.
Signs And Symptoms: Although some cases present with black, tarry stool (melena), the blood loss can be subtle, with the anemia symptoms predominating.
Prognosis: The prognosis for angiodysplasia can vary. Generally, it depends on factors such as the severity of the condition, the presence of bleeding, and the effectiveness of the treatment. Angiodysplasia is often managed successfully with endoscopic therapies like argon plasma coagulation or sometimes with medications. Patients with recurrent bleeding may experience anemia and may require ongoing monitoring and treatment. Overall, with appropriate management, many individuals can lead a good quality of life.
Onset: Angiodysplasia typically affects older adults, with the condition most commonly being diagnosed in individuals over the age of 60. It is characterized by abnormal, fragile blood vessels in the gastrointestinal tract, which can lead to bleeding and anemia.
Prevalence: Angiodysplasia is a condition characterized by abnormal, fragile blood vessels in the gastrointestinal tract. The prevalence of angiodysplasia increases with age and is more common in individuals over the age of 60. It is estimated to be found in about 1-6% of the general population, with a higher incidence in those with conditions such as chronic kidney disease or aortic stenosis.
Epidemiology: Angiodysplasia is an abnormality in the blood vessels of the gastrointestinal tract, predominantly seen in the elderly. It accounts for around 4-7% of cases of lower GI bleeding. The incidence increases with age, most commonly affecting individuals over 60 years old. The condition is slightly more prevalent in females than in males.
Intractability: Angiodysplasia can vary in its severity and responsiveness to treatment. While many cases can be managed with interventions such as endoscopic procedures, medications, or surgery, some cases may be difficult to control and could be considered intractable if they do not respond well to these treatments. The intractability depends on individual patient factors, including the extent and location of the vascular lesions and overall health.
Disease Severity: Angiodysplasia severity can vary widely. It often depends on the extent and location of the vascular lesions. Some people may experience mild symptoms, such as occasional gastrointestinal bleeding, while others can have severe, life-threatening hemorrhages. The condition is more common in older adults and can sometimes require medical or surgical intervention to manage bleeding.
Healthcare Professionals: Disease Ontology ID - DOID:2494
Pathophysiology: Histologically, it resembles telangiectasia and development is related to age and strain on the bowel wall. It is a degenerative lesion, acquired, probably resulting from chronic and intermittent contraction of the colon that is obstructing the venous drainage of the mucosa. As time goes by the veins become more and more tortuous, while the capillaries of the mucosa gradually dilate and precapillary sphincter becomes incompetent. Thus is formed an arteriovenous malformation characterized by a small tuft of dilated vessels.Although angiodysplasia is probably quite common, the risk of bleeding is increased in disorders of coagulation. A classic association is Heyde's syndrome (coincidence of aortic valve stenosis and bleeding from angiodysplasia).
In this disorder, von Willebrand factor (vWF) is proteolysed due to high shear stress in the highly turbulent blood flow around the aortic valve. vWF is most active in vascular beds with high shear stress, including angiodysplasias, and deficiency of vWF increases the bleeding risk from such lesions.Warkentin et al. argue that apart from aortic valve stenosis, some other conditions that feature high shear stress might also increase the risk of bleeding from angiodysplasia.
Carrier Status: Carrier status is not applicable for angiodysplasia. Angiodysplasia is a condition characterized by abnormal blood vessels in the gastrointestinal tract, typically the colon, and is not a genetically inherited disorder. Therefore, issues of carrier status do not arise in relation to this condition.
Mechanism: **Mechanism of Angiodysplasia:**

Angiodysplasia is a vascular condition characterized by small, fragile, and abnormal blood vessels, primarily in the gastrointestinal (GI) tract. These abnormalities are often dilated capillaries, venules, and arterioles in the mucosal and submucosal layers of the intestine, which can lead to bleeding.

**Molecular Mechanisms:**

1. **Vascular Endothelial Growth Factor (VEGF):**
- Increased levels of VEGF have been reported in patients with angiodysplasia. VEGF is a signal protein that stimulates the growth of new blood vessels (angiogenesis) and may contribute to the formation of these abnormal vascular structures.

2. **Matrix Metalloproteinases (MMPs):**
- MMPs are enzymes that degrade various components of the extracellular matrix. Overexpression of MMPs has been associated with the breakdown of normal vascular architecture and the formation of fragile, abnormal vessels in angiodysplasia.

3. **Mechanical Stress:**
- The repetitive stretching and contraction of the muscular walls of the intestines can induce mechanical stress, leading to microvascular changes and the formation of angiodysplastic lesions, particularly in the colon.

4. **Hypoxia:**
- Chronic low oxygen levels (hypoxia) in the mucosa can stimulate angiogenesis through the hypoxia-inducible factor (HIF) pathway, promoting the development of abnormal blood vessels seen in angiodysplasia.

These mechanisms collectively contribute to the development and progression of angiodysplasia, leading to its associated clinical manifestations, primarily gastrointestinal bleeding.
Treatment: If the anemia is severe, blood transfusion is required before any other intervention is considered. Endoscopic treatment is an initial possibility, where cautery or argon plasma coagulation (APC) treatment is applied through the endoscope. Failing this, angiography and embolization with particles is another microinvasive treatment option, which avoids the need for surgery and bowel resection. Here, the vessel supplying the angiodysplasia is selectively catheterized and embolized with microparticles. Resection of the affected part of the bowel may be needed if the other modalities fail. However, the lesions may be widespread, making such treatment impractical.If the bleeding is from multiple or inaccessible sites, systemic therapy with medication may be necessary. First-line options include the antifibrinolytics tranexamic acid or aminocaproic acid. Estrogens can be used to stop bleeding from angiodysplasia. Estrogens cause mild hypercoagulability of the blood. Estrogen side effects can be dangerous and unpleasant in both sexes. Changes in voice and breast swelling is bothersome in men, but older women often report improvement of libido and perimenopausal symptoms. (The worries about hormone replacement therapy/HRT, however, apply here as well.)In difficult cases, there have been positive reports about octreotide and thalidomide.In severe cases or cases not responsive to either endoscopic or medical treatment, surgery may be necessary to arrest the bleeding.
Compassionate Use Treatment: For angiodysplasia, compassionate use and off-label or experimental treatments may include:

1. **Thalidomide**: This medication, typically used for other conditions like multiple myeloma, has been reported in some cases to help reduce bleeding associated with angiodysplasia.

2. **Bevacizumab**: An anti-VEGF (vascular endothelial growth factor) monoclonal antibody used in cancer therapy. Some reports suggest it might reduce bleeding related to angiodysplasia.

3. **Lanreotide or Octreotide**: These somatostatin analogs, typically used for acromegaly and neuroendocrine tumors, have been considered in managing bleeding in angiodysplasia due to their inhibitory effects on gastrointestinal hormones.

4. **Estrogen-Progesterone Therapy**: Historically used for bleeding disorders, although its use has declined due to limited evidence and potential side effects.

These treatments are not standard and should be considered carefully by healthcare professionals based on individual patient needs and the latest research.
Lifestyle Recommendations: For angiodysplasia, lifestyle recommendations may include:

1. **Dietary Considerations**:
- Eat a balanced diet rich in fiber to prevent constipation and avoid straining during bowel movements.
- Stay hydrated by drinking plenty of water.
- Avoid excessive alcohol and caffeine intake as they can irritate the gastrointestinal system.

2. **Regular Exercise**:
- Engage in moderate exercise, such as walking or swimming, to improve overall cardiovascular health and bowel function.

3. **Medication Management**:
- Follow the doctor's advice regarding medications. Some patients may need medication to manage symptoms or reduce bleeding risk.

4. **Avoid NSAIDs**:
- Avoid non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and aspirin, as they can increase the risk of gastrointestinal bleeding.

5. **Monitor Symptoms**:
- Keep track of any symptoms such as blood in the stool, fatigue, or dizziness, and report them to a healthcare provider promptly.

6. **Regular Check-ups**:
- Schedule regular medical check-ups to monitor the condition and adjust treatment as necessary.

These lifestyle changes can help manage symptoms and improve overall well-being for individuals with angiodysplasia.
Medication: Angiodysplasia typically involves abnormal blood vessels in the gastrointestinal tract. Treatment may include medications such as:

1. **Iron supplements** - To address anemia from chronic blood loss.
2. **Hormonal therapy** (e.g., estrogen-progesterone) - Although less commonly used, it can help stabilize bleeding in some cases.
3. **Octreotide** - A synthetic hormone that can decrease bleeding by reducing blood flow to the angiodysplasia sites.

While medication can be part of the management, other treatments like endoscopic procedures or surgery might be necessary depending on the severity and location of the bleeding. Always consult a healthcare provider for a treatment plan specific to individual cases.
Repurposable Drugs: Repurposable drugs that have shown potential for treating angiodysplasia primarily include:

1. **Thalidomide**: This drug has anti-angiogenic properties and has been used off-label for treating bleeding due to angiodysplasia.
2. **Octreotide**: A somatostatin analog that can reduce gastrointestinal bleeding by decreasing splanchnic blood flow.
3. **Tranexamic Acid**: An antifibrinolytic that can help reduce bleeding episodes.

These treatments may not be universally effective and should be used under medical guidance.
Metabolites: Angiodysplasia is a vascular condition affecting the gastrointestinal tract, characterized by the presence of abnormal, dilated blood vessels. It is not typically associated with specific metabolites. The condition primarily causes gastrointestinal bleeding and can lead to symptoms such as anemia. Diagnosis often relies on endoscopic procedures, and treatment may involve endoscopic therapies, medications, or surgery, depending on the severity and recurrence of bleeding. Understanding the exact biochemical or metabolic changes in angiodysplasia remains an area for ongoing research.
Nutraceuticals: For angiodysplasia, there is limited evidence supporting the use of specific nutraceuticals for treatment. Angiodysplasia, a vascular malformation in the gastrointestinal tract, is often managed with medical procedures and medications rather than nutraceuticals. Current treatments may include endoscopic therapies, iron supplementation for anemia, and sometimes medications to reduce bleeding. Always consult a healthcare provider for personalized medical advice.
Peptides: For angiodysplasia, a gastrointestinal condition characterized by abnormal blood vessels, peptide therapies are not currently a standard treatment. The focus is typically on managing symptoms and controlling bleeding. Treatment approaches may include endoscopic procedures, medications, and, in some cases, surgery. While peptide-based therapies might hold future potential, they are not a recognized treatment option for angiodysplasia as of now.